Danaher Corporation (NYSE:DHR) is Koa Wealth Management LLC's 8th Largest Position

Key Points

• Koa Wealth Management LLC increased its holdings in Danaher Corporation by 13.7%, owning 18,548 shares valued at approximately $3.8 million and making it the firm's 8th largest position.
• Danaher reported earnings of $1.80 per share for the latest quarter, surpassing analysts' expectations and achieving a 3.4% year-over-year revenue growth.
• Institutional investors own over 79% of Danaher's stock, with several hedge funds recently adjusting their stakes, indicating significant interest in the company.

Koa Wealth Management LLC grew its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 13.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,548 shares of the conglomerate's stock after buying an additional 2,239 shares during the quarter. Danaher accounts for approximately 3.1% of Koa Wealth Management LLC's holdings, making the stock its 8th biggest holding. Koa Wealth Management LLC's holdings in Danaher were worth $3,802,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in DHR. Heck Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter worth about $27,000. GHP Investment Advisors Inc. raised its position in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the period. Sierra Ocean LLC raised its position in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher in the 1st quarter worth about $31,000. Finally, Dunhill Financial LLC raised its position in Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of NYSE:DHR traded down $0.73 on Monday, hitting $199.83. 2,565,844 shares of the company were exchanged, compared to its average volume of 4,853,395. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.90. The stock's 50 day moving average price is $198.46 and its 200 day moving average price is $200.62. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $143.09 billion, a P/E ratio of 42.52, a price-to-earnings-growth ratio of 2.80 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the previous year, the firm posted $1.72 earnings per share. The business's revenue for the quarter was up 3.4% compared to the same quarter last year. Sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. UBS Group reduced their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. HSBC reduced their target price on shares of Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective on the stock in a research note on Friday, July 11th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Finally, Jefferies Financial Group dropped their price objective on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research note on Tuesday, April 22nd. Three equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $247.61.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.